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Abstract 
Background and purpose: The N-methyl-D-aspartate (NMDA) receptor is 
an important target of alcohol action in the brain. Recent studies in this 
laboratory have demonstrated that alcohol-sensitive positions in the 
intersubunit interfaces of the M3 and M4 domains of GluN1 and GluN2A 
subunits interact with respect to ethanol sensitivity and receptor kinetics, and 
that alcohol-sensitive positions in the M domains of GluN2A and GluN2B 
subunits differ. In this study we tested for interactions among alcohol-
sensitive positions at the M domain intersubunit interfaces in GluN1/GluN2B 
NMDA receptors. 
Experimental approach: We used whole-cell patch-clamp recording in 
tsA201 cells expressing tryptophan substitution mutants at ethanol-sensitive 
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positions in the GluN1 and GluN2B NMDA receptor subunits to test for 
interactions among positions. 
Key results: Six pairs of positions in GluN1/GluN2B significantly interacted to 
regulate ethanol inhibition: Gly638/Met824, Gly638/Leu825, Phe639/Leu825, 
Phe639/Gly826, Met818/Phe637 and Val820/Phe637. Tryptophan substitution 
at Met824 or Leu825 in GluN2B did not alter ethanol sensitivity, but 
interacted with positions in the GluN1 M3 domain to regulate ethanol action, 
whereas tryptophan substitution at Gly638, which is the cognate of an 
ethanol-sensitive position in GluN2A, did not alter ethanol sensitivity or 
interact with positions in GluN1. Two and three pairs of positions interacted to 
regulate glutamate steady-state and peak current EC50, respectively, and one 
pair interacted with respect to macroscopic desensitization. 
Conclusions: Despite highly-conserved M domain sequences and similar 
ethanol sensitivity in the GluN2A and GluN2B subunits, the manner in which 
these subunits interact with the GluN1 subunit to regulate ethanol sensitivity 
and receptor kinetics differs. 
 
Keywords: glutamate receptor; alcohol; membrane-associated domains; 
electrophysiology; mutant 
 
Abbreviations: BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N’,N’-
tetraacetic acid; EtOH, Ethanol 
 
Introduction 
 
Alcohol abuse and alcoholism are behavioral disorders involving 
altered synaptic transmission in the CNS (Koob, 2003; Gass and Olive, 
2008). The N-methyl-D-aspartate (NMDA) receptor, a subtype of 
glutamate-gated ion channel, is among the most important target sites 
of alcohol in the brain (Woodward, 1999; Krystal et al., 2003; Peoples, 
2003; Chandrasekar, 2013). At relevant concentrations, ethanol 
inhibits NMDA receptor-mediated ionic current via changes in channel 
mean open time and opening frequency (Lima-Landman and 
Albuquerque, 1989; Lovinger et al., 1989; Wright et al., 1996). 
Ethanol appears to inhibit NMDA receptors via low affinity interactions 
with a number of positions in the membrane-associated (M) domains 
that modulate ion channel gating (Ronald et al., 2001; Ren et al., 
2003a, 2003b, 2007, 2012, 2013; Honse et al., 2004; Smothers and 
Woodward, 2006; Zhao et al., 2015), but the manner in which ethanol 
interacts with its molecular sites to modulate the activity of NMDA 
receptors is still incompletely understood. 
 
Previous studies in this and other laboratories have identified a 
number of amino acid positions in NMDA receptor GluN1 and GluN2A 
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subunit membrane-associated (M) domains that influence both gating 
and alcohol sensitivity of the ion channel. Following the initial finding 
that a position in the M3 domain of the GluN1 subunit, Phe639, can 
regulate NMDA receptor ethanol sensitivity (Ronald et al., 2001), a 
number of studies from this laboratory in the GluN2A subunit found 
that the cognate position, Phe637, in the M3 domain, and three other 
positions in the M3 and M4 domains, Phe636, Met823, and Ala825, 
regulate NMDA receptor ethanol inhibition and ion channel kinetics 
(Ren et al., 2003a, 2003b, 2007, 2012, 2013; Honse et al., 2004). 
Previous studies have demonstrated that these and other positions in 
the GluN1 and GluN2A subunits can interact to regulate ethanol 
sensitivity and ion channel function (Smothers and Woodward, 2006; 
Ren et al., 2008, 2012; Xu et al., 2015). The results of these studies, 
taken together with the solved structures of ionotropic glutamate 
receptors that show the identified alcohol-sensitive positions in the M3 
domain of one subunit type closely apposed to those in the M4 domain 
of the other subunit type (Sobolevsky et al., 2009; Karakas and 
Furukawa, 2014), predict the existence of four sites of alcohol action: 
two at the GluN1 M3/GluN2A M4 interfaces, and the other two at the 
GluN1 M4/GluN2A M3 interfaces (Ren et al., 2012). 
 
Although the GluN2A subunit predominates in the mammalian 
brain, a number of studies suggest a major role for the GluN2B subunit 
in the action of alcohol on the brain (Boyce-Rustay and Holmes, 2005; 
Kash et al., 2008, 2009; Wills et al., 2012), and consequently for the 
importance of the GluN2B subunit as a potential therapeutic target for 
the treatment of alcohol addiction (Chazot, 2004; Nagy, 2004; Gogas, 
2006; Holmes et al., 2013). At present, however, the understanding of 
the molecular mechanism of alcohol modulation of the GluN2B subunit 
is limited. A recent study from this laboratory reported that alcohol-
sensitive positions at the M3-M4 intersubunit interfaces of 
GluN1/GluN2A NMDA receptors can interactively regulate both alcohol 
sensitivity and ion channel kinetics (Ren et al., 2012). Based on the 
high homology between the GluN2A and GluN2B subunit M domains 
(Ryan et al., 2013), we tested whether we could observe similar 
interactions among the cognate positions in GluN1/GluN2B NMDA 
receptors. In the present study, we report that multiple pairs of 
positions in the GluN1/GluN2B NMDA receptor interact to modulate 
ethanol inhibition and ion channel gating. Compared to previous 
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results obtained in the GluN1/GluN2A NMDA receptor, the interactions 
we observed among positions in the GluN1/GluN2B NMDA receptor 
differ with respect to both ethanol sensitivity and ion channel kinetics, 
which is consistent with previous observations of differences in 
alcohol-sensitive positions between the GluN2A and GluN2B subunits 
(Zhao et al., 2015). 
 
Methods 
 
Site-directed mutagenesis, cell culture and transfection 
 
Site-directed mutagenesis in plasmids containing GluN1 or 
GluN2B subunit cDNA was performed using the QuickChange II kit 
(Agilent Technologies, Santa Clara, CA, USA), and all mutations were 
verified by DNA sequencing. Transformed human embryonic kidney 
(tsA 201) cells were seeded in 35-mm poly-D-lysine coated dishes, 
and cultured in minimum essential medium (MEM) containing 10% 
heat-inactivated fetal bovine serum to 70 - 95% confluence. Cells were 
transfected with cDNA for the GluN1-1a, GluN2B subunits and green 
fluorescent protein (pGreen Lantern; Invitrogen, Carlsbad, CA) at a 
2:2:1 ratio using calcium phosphate transfection kit (Invitrogen). After 
transfection, 200 uM dl-2-amino-5-phosphonovaleric acid (APV) and 
100 μM ketamine were added to the culture medium to protect cells 
from receptor-mediated excitotoxicity. Cells were used for recordings 
within 48 hr following transfection. Antagonists were removed before 
recording by extensive washing. 
 
Electrophysiological recording 
 
Whole-cell patch-clamp recording was performed at room 
temperature using an Axopatch 1D or 200B amplifier (Axon 
Instruments Inc., Foster City, CA, USA) as described previously (Ren 
et al., 2012). Gigaohm seals were obtained using patch-pipettes with 
tip resistances of 2 - 4 MΩ, and series resistances of 1 - 5 MΩ were 
compensated by 80%. Cells were voltage-clamped at -50 mV and 
superfused in an external recording solution containing (in mM): 150 
NaCl, 5 KCl, 0.2 CaCl2, 10 HEPES, 10 glucose, and 20 sucrose. The 
ratio of added HEPES free acid and sodium salt was calculated to result 
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in a solution pH of 7.4 (Buffer Calculator, R. Beynon, University of 
Liverpool; available at www.liv.ac.uk/buffers); final pH was adjusted, if 
necessary, using HCl or NaOH. Low Ca2+ was used to minimize NMDA 
receptor inactivation, and EDTA, 10 μM, was included to eliminate the 
fast current relaxation due to high affinity Zn2+ inhibition (Low et al., 
2000; Zheng et al., 2001). Solutions of agonists and ethanol were 
prepared fresh daily and applied to cells using a stepper motor-driven 
solution exchange apparatus (Warner Instruments, Hamden, CT, USA) 
and three-barrel square glass tubing of internal diameter 600 μm. The 
intracellular recording solution (patch-pipette) contained (in mM) 140 
CsCl, 2 Mg4ATP, 10 BAPTA, and 10 HEPES. The pH was adjusted to 7.4 
using HCl or NaOH, and the osmolarity to 310 mOsmol/kg using 
sucrose. In glutamate concentration-response experiments, cells were 
lifted off the surface of the dish after obtaining a gigaohm seal to 
increase the speed of solution exchange. The 10 - 90% rise time for 
solution exchange under these conditions is ~1.5 ms (Ren et al., 
2003a). Data were filtered at 2 kHz (8-pole Bessel) and acquired at 5 
kHz on a computer using a DigiData interface and pClamp software 
(Molecular Devices). 
 
Data analysis 
 
In concentration-response experiments, IC50 or EC50 and n 
(slope factor) were calculated using the equation: y = Emax / 1 + (IC50 
or EC50 / x)n, where y is the measured current amplitude, x is 
concentration, and Emax is the maximal current amplitude. Statistical 
differences among concentration-response curves were determined by 
comparing log transformed IC50 or EC50 values from fits to data 
obtained from individual cells using one-way analysis of variance 
(ANOVA) followed by the Dunnett test. All values are reported as 
means ± S.E.M.  
 
Significant interactions among mutants at multiple positions 
were determined by two-way ANOVA and by mutant cycle analysis. 
Two-way ANOVA of log-transformed ethanol IC50 or glutamate EC50 
values was performed using the effect of substitution at each of two 
positions as the two dimensions of the analysis, such that a 
statistically-significant interaction between these dimensions in the 
ANOVA would indicate that the amino acid side chain at one position 
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could influence the effect of the side chain at the other position on 
receptor function. Mutant cycle analysis was performed essentially as 
described by Venkatachalan and Czajkowski (2008). Tryptophan 
substitution mutations were introduced singly and in combination at 
positions in GluN1 and GluN2B subunits proposed to interact, and 
ethanol IC50 and glutamate EC50 were determined in each mutant. The 
interaction free energy, ΔΔGINT, for mutations at two positions is the 
difference in apparent free energy between the parallel energies in the 
cycle (i.e., from the wild-type and either single mutant to the other 
single mutant and the dual mutant). Alternatively, ΔΔGINT may be 
considered as a comparison between the apparent energy change due 
to the dual mutant and that due to both of the single mutants, such 
that nonzero values of ΔΔGINT indicate an interaction between the 
positions. Interaction free energies among mutated positions were 
calculated using natural logarithms (ln) of either ethanol IC50 or 
glutamate EC50 values obtained from wild-type and mutant subunit 
combinations, using the equation ΔΔGINT = RT [ln(WT) + 
ln(mut1,mut2) – ln(mut1) – ln(mut2)]. A statistically significant 
difference between ΔΔGINT and zero energy was taken to indicate an 
interaction between the two positions. Statistically significant 
differences were determined by using one sample t tests, with degrees 
of freedom df = NWT + NMUT1 + NMUT2 + NMUT1,MUT2 – 4, NX equal to the 
number of cells used for each combination of wild-type and mutant 
subunits, and S.E.M. determined from propagated errors. 
 
Materials 
 
Ethanol (EtOH; 95%, prepared from grain) was obtained from 
Aaper Alcohol & Chemical Co. (Shelbyville, KY, USA) and all other 
drugs and chemicals were obtained from Sigma Chemical Co. (St. 
Louis, MO, USA). 
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Results 
 
Single mutations in the M3 and M4 domains of GluN1 
and GluN2B subunits alter ethanol inhibition of NMDA 
receptors. 
 
Previous work in this laboratory has identified significant 
interactions at four pairs of positions in the M3 and M4 domains of the 
GluN1 and GluN2A subunits with respect to ethanol inhibition and 
receptor kinetics (Ren et al., 2012). We have also recently shown that 
in the GluN2B subunit, only two positions corresponding to GluN2A 
alcohol-sensitive positions, F637 and G826, regulated ethanol 
sensitivity (Zhao et al., 2015). In the present study, we first tested 
putative sites of ethanol action in the M3-M4 domains of the GluN1 
subunit when expressed with the GluN2B subunit using a tryptophan-
scanning approach (Fig 1). All of the tryptophan substitution mutants 
we tested in this study yielded functional NMDA receptors, although 
some mutations in the GluN1 and GluN2B subunits noticeably changed 
receptor characteristics, such as deactivation or macroscopic 
desensitization (Fig 2A). All tryptophan substitutions in GluN1 M3 
showed significantly decreased ethanol sensitivity, while tryptophan 
substitution at any of the four positions in GluN1 M4 did not alter 
ethanol sensitivity (Fig 2B, C). 
 
Dual mutations in the M3 and M4 domains of GluN1 and 
GluN2B subunits alter ethanol inhibition of NMDA 
receptors. 
 
Next we tested the ethanol sensitivity of receptors with 
tryptophan substitutions in both the GluN1 and GluN2B subunits at 
positions in the M3-M4 domain interfaces that are predicted to interact 
based on our previous study in GluN1/GluN2A NMDA receptors (Ren et 
al., 2012). We found that all mutant combinations tested formed 
functional NMDA receptors, with the exception of 
GluN1(A821W)/GluN2B(F637W) (not shown). In some cases the 
mutations altered receptor function (Fig 3A). In particular, the two 
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combinations involving the GluN1(G638W) mutant affected receptor 
kinetics, noticeably changing the onset and offset rates of ethanol 
inhibition, and the deactivation rate. Recordings from cells expressing 
this subunit also had an erratic appearance that was apparently due to 
slow fluctuations in current amplitude. Preliminary results suggest that 
these changes are due at least in part to a prolongation of mean open 
time (Y. Zhao, unpublished results). Four out of ten dual mutant 
combinations tested showed significantly altered ethanol sensitivity 
compared with the wild-type receptor. In some cases, dual mutations 
in both the GluN1 and GluN2B subunits influenced ethanol sensitivity 
in a manner that was non-additive compared to the individual 
mutations, which indicates a functional interaction at these two 
positions in mediating the action of the ethanol on the receptor (Fig 
3B, 3C). 
 
Positions in the M3 and M4 domains of GluN1 and 
GluN2B subunits can interact to regulate ethanol 
inhibition of NMDA receptors. 
 
A previous study from this laboratory reported intersubunit 
interactions between M3 and M4 domain positions in the GluN1 and 
GluN2A subunits (Ren et al., 2012). In order to test for possible 
interactions among the corresponding positions in the GluN1 and 
GluN2B subunits, we used both two-way analysis of variance (ANOVA) 
on log-transformed ethanol IC50 values and mutant cycle analysis. We 
found that each of the two positions in the GluN1 M3 domain 
interacted with two positions in GluN2B M4. Using both types of 
analysis, we observed significant interactions with respect to ethanol 
sensitivity between GluN1(Gly638) and either Met824 or Leu825 in 
GluN2B, and between GluN1(Phe639) and either Leu825 or Gly826 in 
GluN2B (Fig. 4 and Table1). We also observed interactions of the 
GluN2B M3 positions tested with multiple positions in the GluN1 M4 
domain. We detected significant interactions of GluN2B(Phe637) with 
the GluN1 residues Met818 or Val820, but not Leu819 (Fig. 5 and 
Table1). In contrast, there were no significant interactions detected 
between GluN2B(Phe638) and any of the three positions tested in the 
GluN1 subunit M4 domain. 
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Positions in the M3 and M4 domains of GluN1 and 
GluN2B subunits can interactively regulate glutamate 
potency. 
 
Studies from this laboratory have shown that positions in the M3 
and M4 domains of different subunits can interactively regulate 
receptor function (Ren et al., 2008; Ren et al., 2012). In this study, 
we tested three pairs of mutants which exhibited significant 
interactions in regulating ethanol action. Among these combinations, 
we tested for interactions with respect to glutamate peak and steady-
state current EC50 values by using two-way analysis of variance as well 
as mutant cycle analysis. Of the three mutant combinations tested, 
glutamate peak current EC50 was altered in 
GluN1(G638W)/GluN2B(M824W), and glutamate steady-state current 
EC50 was altered in both GluN1(G638W)/GluN2B(M824W) and 
GluN1(M818W)/GluN2B(F637W) (Fig. 6). We observed significant 
interactions among all three pairs tested with respect to glutamate 
peak current EC50 (Fig. 7 and Table 2), and in two pairs with respect to 
glutamate steady-state current EC50 (Fig. 8 and Table 3). 
 
Interaction of GluN1(Gly638) and GluN2B(Met824) in 
regulation of channel desensitization. 
 
A previous study from this laboratory reported that a tryptophan 
mutation at position 823 in the M4 domain of the GluN2A subunit can 
markedly increase desensitization (Ren et al., 2003a). In the present 
study, tryptophan substitution at GluN2B(Met824) also significantly 
increased macroscopic desensitization (Fig. 2A), as assessed by using 
steady-state to peak current ratio (Iss:Ip), whereas tryptophan 
substitution at GluN1(Gly638) did not alter desensitization (Fig. 9A). 
However, the effect of the GluN2B(Met824W) mutation on 
desensitization was partially reversed by coexpression with the 
GluN1(Gly638W) mutant subunit. Both two-way analysis of variance 
and mutant cycle analysis of steady-state to peak current ratios 
indicated a significant interaction between these positions with respect 
to apparent desensitization (Fig. 9B,C). 
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Discussion 
 
We and others have previously shown that substitutions at 
positions in the M3 and M4 domains of the GluN1 and GluN2B subunits 
can change NMDA receptor ethanol sensitivity (Ronald et al., 2001; 
Smothers and Woodward, 2006; Ren et al., 2012; Zhao et al., 2015), 
and that alcoholsensitive positions in the M domains of the GluN1 and 
GluN2A subunits can functionally interact (Smothers and Woodward, 
2006; Ren et al., 2008, 2012; Xu et al., 2015). In the present study, 
we have found that mutations in the M3, but not M4, domain of the 
GluN1 subunit regulate ethanol sensitivity when combined with the 
GluN2B subunit, and have demonstrated that introduction of dual 
tryptophan substitutions into positions in the GluN1 and GluN2B 
subunits at the M3 and M4 intersubunit interfaces can reveal functional 
interactions among these positions with respect to regulation of 
ethanol sensitivity and ion channel function. 
 
As in a recent study from this laboratory (Ren et al., 2012), in 
the present study we have used both two-way analysis of variance and 
dual mutant cycle analysis to test for interactions between positions at 
the NMDA receptor M3 and M4 domain intersubunit interfaces. Both 
tests use log-transformed ethanol IC50 values or glutamate EC50 values 
to determine whether the effects of mutations at two positions are 
independent. We and others have previously used mutant cycle 
analysis to indicate side-chain interactions regulating agonist or 
inhibitor potency (Kash et al., 2003; Venkatachalan and Czajkowski, 
2008; Laha and Wagner, 2011). In the present study, as in a previous 
study (Ren et al., 2012), we used tryptophan substitution to detect 
interactions between positions, rather than alanine substitution, which 
is typically used (Venkatachalan and Czajkowski, 2008; Laha and 
Wagner, 2011). Although tryptophan substitution could introduce side-
chain interactions that are not normally present, we used it in the 
present study because our previous work has shown tryptophan to be 
the substituent most likely to alter ethanol sensitivity and ion channel 
function. Furthermore, if the cavities bounded by the tested positions 
form ethanol binding sites in GluN1/GluN2B receptors, as we have 
proposed for GluN1/GluN2A receptors (Ren et al., 2012), dual 
tryptophan substitutions would be most likely to exclude the binding of 
ethanol. 
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We recently reported that only two of four positions in the 
GluN2B subunit corresponding to alcohol-sensitive positions in the 
GluN2A subunit regulated ethanol sensitivity (Ren et al., 2012; Zhao 
et al., 2015). In contrast, we found in the present study that the 
positions in the GluN1 subunit regulating alcohol sensitivity are the 
same whether it is expressed with the GluN2A or GluN2B subunit. 
Tryptophan substitution at either F638 or F639 in the GluN1 M3 
domain, but not at any of four positions from 818-821 in the GluN1 M4 
domain, significantly altered ethanol IC50 values in GluN1/GluN2B 
NMDA receptors, which agrees with previous results in GluN1/GluN2A 
receptors (Smothers and Woodward, 2006; Ren et al., 2012). Similar 
results were obtained using cysteine substitutions (Xu et al., 2015), 
although alanine substitution at GluN1(L819) was reported to increase 
ethanol sensitivity in NMDA receptors containing GluN2A, 2B, or 2C 
subunits (Smothers and Woodward, 2006). The results of the present 
study, taken together with those of previous studies, suggest that the 
role of alcohol-sensitive positions in the GluN1 subunit is not strongly 
dependent on the coexpressed GluN2 subunit. 
 
Although the influence of GluN1 M3 and M4 domain residues on 
alcohol sensitivity was similar when expressed with GluN2A or GluN2B 
subunits, interactions among positions at the M3-M4 domain 
intersubunit interfaces appear to differ in GluN1/GluN2A and 
GluN1/GluN2B NMDA receptors. In GluN1/GluN2B subunit-containing 
receptors, we did not detect significant interactions among all 
predicted M3-M4 domain positions. We previously reported that 
GluN1(Leu819) and GluN2A(Phe637) could interactively regulate 
ethanol sensitivity (Ren et al., 2012); however, we did not find an 
interaction between GluN1(Leu819) and the cognate position 
GluN2B(Phe638) with respect to ethanol sensitivity. The explanation 
for this may involve differences in the M3 position in GluN2A and 
GluN2B. Although GluN2A(Phe637) strongly regulates ethanol action 
on the NMDA receptor (Ren et al., 2007), GluN2B(Phe638) does not 
(Zhao et al., 2015). These differences agree with our recent findings 
showing differences in ethanol action on the GluN2A and GluN2B 
subunits, despite high sequence homology in the M3 and M4 domains 
(Zhao et al., 2015). We also observed differences among positions in 
GluN2A and GluN2B regarding multiple interactions with GluN1 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
British Journal of Pharmacology, Vol. 173, No. 12 (June 2016): pg. 1950-1965. DOI. This article is © Wiley and permission 
has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
12 
 
residues (Fig. 10). Out of four positions in GluN2A that regulate 
ethanol sensitivity, only Phe637 in M3 interacted with two positions in 
GluN1 M4, and one interaction appeared to be stronger than the other 
(Ren et al., 2012), whereas the cognate residue in GluN2B, Phe638, 
did not interact with any GluN1 position. Both positions in the GluN1 
M3 domain interacted equivalently with two positions in the GluN2B M4 
domain, the more distal of which, G826, is located approximately 8.6 
Å away (measuring from the nearest atom) in the native protein. 
GluN2B(F637) in M3 significantly interacted with two positions in 
GluN1 M4, Met818 and Val820. Interestingly, GluN2B(F637) did not 
interact with its predicted opposing side chain, GluN1(Leu819), but 
interacted significantly with GluN1(M818), which in the native protein 
is located on the opposite face of the alpha-helix at a distance of 12.8 
Å. The observation that the interaction of GluN2B(F637) with 
GluN1(M818) appeared to be weaker than that with GluN1(V820) likely 
reflects the greater distance between these positions. Furthermore, 
the interactions observed between distant side chains, which in some 
cases are located on opposite helical faces, most likely involve long-
distance functional changes (Ren et al., 2008; Ren et al., 2012), or to 
additional positions that interact with one or both members of the pair 
(Xu et al., 2015). The reason for the presence of these long-distance 
interactions with respect to ethanol inhibition in GluN2B, but not 
GluN2A, receptors is not clear, but given the high sequence homology 
in these regions, may result from subtle structural changes (Zhao et 
al., 2015), differences in gating (Banke et al., 2003; Erreger et al., 
2005), or perhaps differences in ethanol action between the subunit 
types. 
 
Because ethanol can exert its action at multiple positions in the 
NMDA receptor, it is likely that those positions would interact 
functionally to regulate ethanol sensitivity. The first studies 
demonstrated that residues within the same subunit may interact with 
each other to modulate ethanol action. Smothers and Woodward 
(2006) demonstrated that alanine substitution at GluN1(Phe639) 
significantly reduced ethanol sensitivity, and that tryptophan 
substitutions at certain positions in the GluN1 subunit M4 domain could 
reverse the effect of the GluN1(Phe639) alanine mutant. Similarly, a 
study from this laboratory demonstrated that Phe637 and Met823 in 
the GluN2A subunit can interactively regulate ethanol sensitivity as 
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well as NMDA receptor function (Ren et al., 2008). We recently 
reported significant interactions with respect to ethanol action between 
pairs of residues in the M3 domain of one subunit type and the M4 
domain of the other in GluN1/GluN2A receptors (Ren et al., 2012). 
Pairs of side chains in that study were tested based on the predicted 
proximity of their cognate positions in the solved structure of the 
GluA2 subunit (Sobolevsky et al., 2009); the same interactions in the 
M3 and M4 domains of the GluN1 and GluN2B subunits would be 
predicted from the recently-published structure of the GluN1/GluN2B 
receptor (Karakas and Furukawa, 2014). Although not all of the 
predicted interactions in the present study were confirmed, we 
nevertheless identified a number of pairs of positions that interactively 
regulated GluN1/GluN2B NMDA receptor ethanol sensitivity. 
Interestingly, in some cases a mutation at one position that by itself 
did not affect ethanol sensitivity could reverse the effect of a second 
mutation at an interacting position. At type 1 sites (GluN1 M3/GluN2B 
M4; Fig. 10), tryptophan substitution at either G638 or F639 in the 
GluN1 subunit M3 domain significantly decreased ethanol sensitivity. 
Although tryptophan substitution at M824 or L825, the respective 
nearest neighboring positions in the GluN2B subunit M4 domain, had 
no effect on ethanol IC50 values, these mutations could reverse the 
effects of GluN1 M3 mutations on ethanol sensitivity: in NMDA 
receptors bearing dual tryptophan mutations at G638/M824 or 
F639/L825, ethanol IC50 values did not differ from that of the wild-type 
receptor. Similar results were observed for mutations at the type 2 
site, although only the GluN2B(F637) position regulated ethanol 
sensitivity. These results are similar to those we obtained previously in 
GluN1/GluN2A subunits, in which intersubunit interactions could 
reverse the effects of mutations at ethanol-sensitive positions (Ren et 
al., 2012). The simplest interpretation of our present findings for pairs 
of adjacent positions at intersubunit interfaces is that mutations at 
positions that do not by themselves affect ethanol sensitivity can 
oppose changes in ethanol sensitivity at interacting positions by 
altering ethanol binding to these sites. For pairs of positions that are 
not in close proximity, mutations at positions that by themselves do 
not influence ethanol sensitivity may nevertheless introduce forces on 
the M domain helices that oppose the action of ethanol. 
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A number of studies have reported that ethanol can influence 
desensitization states of ligandgated ion channels (Moykkynen et al., 
2003, 2009; Dopico and Lovinger, 2009). In NMDA receptors, the M3 
and M4 domains are both important for ion channel gating (Jones et 
al., 2002; Sobolevsky et al., 2002; Ren et al., 2003a; Schorge and 
Colquhoun, 2003; Yuan et al., 2005; Blank and VanDongen, 2008; 
Chang and Kuo, 2008), and studies from this and other laboratories 
have shown that mutations at ethanol-sensitive positions in the M3 
and M4 domains of GluN1 and GluN2A subunits can alter ion channel 
kinetics, including agonist affinity, desensitization, and mean open 
time (Ronald et al., 2001; Ren et al., 2003a, 2003b, 2007, 2008, 
2013; Smothers and Woodward, 2006). In the present study, we 
observed that glutamate peak and steady-state current EC50 values 
were altered following tryptophan mutagenesis into individual positions 
or pairs of positions in the M domains. Because all of the tested 
positions are at a considerable distance from the ligand-binding 
domain (Low et al., 2003; Yuan et al., 2005; Sobolevsky et al., 2007, 
2009), the changes we identified in glutamate EC50 among these 
mutants most probably result from modifications in ion channel gating 
that reciprocally affect ligand binding. A previous study in this 
laboratory demonstrated that altered glutamate steady-state EC50 
values in mutants at GluN2A(Met823) were highly correlated with 
changes in desensitization, which was most likely due to agonist 
trapping in one or more long-lived closed states (Ren et al., 2003a). 
However, this is not the case in the present study, because in the 
majority of mutants glutamate steady-state current EC50 values were 
altered without a corresponding change in desensitization. The precise 
changes in ion channel gating that underlie the changes in affinity thus 
remain unclear at present, but may involve changes in dwell times of 
either open states or short-lived closed states. Whatever the nature of 
the kinetic changes that accompany M domain mutations, they appear 
to be interactively regulated. Three pairs of residues that interact to 
regulate ethanol sensitivity also interacted to regulate glutamate peak 
current EC50, and two pairs of residues interactively regulated 
glutamate steady-state current EC50. We also observed an interaction 
with respect to macroscopic desensitization for one pair of residues, 
GluN1(Gly638) and GluN2B(Met824). Tryptophan substitution at 
GluN2B(Met824) markedly increased desensitization, as was observed 
at the cognate position in the GluN2A subunit (Ren et al., 2003a). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
British Journal of Pharmacology, Vol. 173, No. 12 (June 2016): pg. 1950-1965. DOI. This article is © Wiley and permission 
has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission for this article 
to be further copied/distributed or hosted elsewhere without the express permission from Wiley. 
15 
 
Tryptophan substitution at GluN1(Gly638) had no effect on 
desensitization when expressed with wild-type GluN2B subunits, but 
partially reversed the effect of the GluN2B(Met824Trp) mutant. Mutant 
cycle analysis of maximal steady-state to peak current ratio revealed a 
significant interaction between these positions. These results suggest 
that the side chains of these two residues are able to interact, at least 
when tryptophan is introduced into both positions, in a manner that 
influences ion channel gating. 
 
In summary, the results of this study identified multiple 
interactions with respect to ethanol inhibition and ion channel gating 
among positions at the intersubunit interfaces of the M3 and M4 
domains forming putative sites of ethanol action in the GluN1/GluN2B 
NMDA receptor. Despite both a high degree of sequence homology in 
the M domains and similar ethanol sensitivity, these interactions differ 
in the GluN2A and GluN2B subunits. 
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Table 1. Mutant Cycle Analysis of Ethanol EC50 
 
Values of ΔGX in kcal mol-1 are RT [ln(R1 IC50 – ln(R2 IC50)], where R1 and R2 refer 
to the NMDA receptor subunit combinations on the left and right sides, respectively, of 
the column headings (WT, wild-type; N1, GluN1 mutant/GluN2B wild-type; N2, GluN1 
widetype/GluN2B mutant; N1/N2B, GluN1 mutant/GluN2B mutant). Values of apparent 
free energy ΔΔGINT in kcal mol-1 are means ± S.E.M. Values of ΔΔGINT, degrees of 
freedom (df), and statistical significance of ΔΔGINT were determined as described in 
the Methods. 
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Table 2. Mutant Cycle Analysis of Glutamate Peak Current (Ip) EC50 
Mutant Pair (GluN1/GluN2B) 
 
Values of ΔGX in kcal mol-1 are RT [ln(R1 EC50 – ln(R2 EC50)], where R1 and R2 refer 
to the NMDA receptor subunit combinations on the left and right sides, respectively, of 
the column headings (WT, wild-type; N1, GluN1 mutant/GluN2B wild-type; N2, GluN1 
wild-type/GluN2B mutant; N1/N2B, GluN1 mutant/GluN2B mutant). Values of 
apparent free energy ΔΔGINT in kcal mol-1 are means ± S.E.M. Values of ΔΔGINT, 
degrees of freedom (df), and statistical significance of ΔΔGINT were determined as 
described in the Methods. 
 
Table 3. Mutant Cycle Analysis of Glutamate Steady-State Current (Iss) EC50  
 
Values of ΔGX in kcal mol-1 are RT [ln(R1 EC50 – ln(R2 EC50)], where R1 and R2 refer 
to the NMDA receptor subunit combinations on the left and right sides, respectively, of 
the column headings (WT, wild-type; N1, GluN1 mutant/GluN2B wild-type; N2, GluN1 
wild-type/GluN2B mutant; N1/N2B, GluN1 mutant/GluN2B mutant). Values of 
apparent free energy ΔΔGINT in kcal mol-1 are means ± S.E.M. Values of ΔΔGINT, 
degrees of freedom (df), and statistical significance of ΔΔGINT were determined as 
described in the Methods. 
 
 
Figure 1 
M3 
GluN1   630  RILGMVWAGFAMIIVASYTANLAAF GluN2A  631     
VSVWAFFAVIFLASYTANLAAFMIQ GluN2B  632     
VSVWAFFAVIFLASYTANLAAFMIQ 
 
M4 
GluN1   811  ENMAGVFMLVAGGIVAGIF GluN2A  822         
YMLAAAMALSLITFIW GluN2B  823         
YMLGAAMALSLITFIC 
 
Fig. 1. Positions in the GluN1 and GluN2B subunit M3 and M4 domains 
constituting putative sites of ethanol action. Partial sequences of the M3 and M4 
domains in GluN1 and GluN2B subunits are shown, with positions in GluN2B 
corresponding to ethanol-sensitive or interacting positions in GluN2A indicated in bold. 
The location of GluN2B(Phe637), the main position regulating ethanol sensitivity in the 
GluN2B subunit (Zhao et al., 2015), is indicated by the arrow. 
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Figure 2 
 
Fig. 2. Ethanol sensitivity of tryptophan mutant subunits in the M3 and M4 
domains of the GluN1 and GluN2B subunits. A. Traces are currents activated by 
10 μM glutamate and 50 μM glycine and their inhibition by 100 mM ethanol in cells 
expressing various single tryptophan substitution mutations in the GluN1 (upper) and 
GluN2B (lower) subunits. One-letter amino acid codes are used. B. Concentration-
response curves show ethanol inhibition of current activated by 10 μM glutamate in 
the presence of 50 μM glycine in cells expressing various single mutant GluN1 (left) 
and GluN2B (right) subunits. Curves shown are the best fits to the equation given in 
the Methods. Data points are means ± S.E. of 5-7 cells. C. Bar graphs show average 
IC50 values for ethanol in cells expressing GluN1 (left) and GluN2B (right) subunits 
containing individual mutations in the M3 and M4 domains. Asterisks indicate IC50 
values that differed significantly from the IC50 value for wild type GluN1/GluN2B 
subunits (**P < 0.01; ANOVA and Dunnett’s test). The black bars show the average 
ethanol IC50 value for the wild-type receptor. Results are means ± S.E. of 5-7 cells. 
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Figure 3 
 
Fig. 3. Ethanol sensitivity of dual tryptophan substitution mutations in the M3 
and M4 domains of the GluN1 and GluN2B subunits. A. Records are currents 
activated by 10 μM glutamate and 50 μM glycine and their inhibition by 100 mM 
ethanol in cells expressing dual mutations in the GluN1 M3 / GluN2B M4 domains 
(upper) and GluN1 M4 / GluN2B M3 domains (lower), as indicated. One-letter amino 
acid codes are used. B. Ethanol concentration-response curves for inhibition of 
glutamate-activated currents in wild-type and mutant receptors. Dual-site substitution 
mutations in the GluN1 M3 / GluN2B M4 domains are shown on the left, and those in 
the GluN1 M4 / GluN2B M3 domains are on the right. Data are means ± S.E. of 4-7 
cells. Curves shown are the best fits to the equation given in the Methods. C. Graphs 
plot average IC50 values for ethanol in dual mutations in the GluN1 M3 / GluN2B M4 
domains (left) and the GluN1 M4 / GluN2B M3 domains (right). Asterisks indicate IC50 
values that differed significantly from the IC50 value for wild type GluN1/GluN2B 
subunits (**P < 0.01; ANOVA and Dunnett’s test). The black bars show the average 
ethanol IC50 value for the wild-type receptor. Results are means ± S.E. of 5-7 cells. 
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Figure 4 
 
Fig. 4. Positions in the M3 domain of the GluN1 subunit and positions in the 
M4 domain of the GluN2B subunit interactively regulate NMDA receptor 
ethanol sensitivity. A-D. Graphs plot ethanol IC50 values vs. the substituent at 
GluN1(G638) or GluN1(F639) for mutants at GluN2B positions 824-826, as indicated. 
Significant interactions between positions detected using log-transformed IC50 values 
are indicated by asterisks (*P < 0.05, **P < 0.01, ****P < 0.0001; two-way ANOVA). 
One-letter amino acid codes are used. E. Mutant cycle analysis of ethanol IC50 values 
for the combination GluN1(Gly638)/GluN2B(Met824), which showed a significant 
interaction with respect to ethanol sensitivity. Apparent free energy values associated 
with various mutations (ΔGx) are given in kcal mol-1. Asterisks indicate a statistically 
significant difference of the apparent interaction energy ΔΔGINT from zero energy 
determined using a one sample t test (****P < 0.0001). 
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Figure 5 
 
Fig. 5. Positions in the M3 domain of the GluN2B subunit and positions in the 
M4 domain of the GluN1 subunit interact to regulate NMDA receptor ethanol 
sensitivity. Graphs plot ethanol IC50 values vs. the substituent at GluN2B(Phe637) 
(A-C) or GluN2B(Phe638) (D-F) for mutants at GluN1 positions 818, 819, 820 and 
821, as indicated. Significant interactions detected using log-transformed IC50 values 
are indicated by asterisks (***P < 0.001, ****P < 0.0001; twoway ANOVA). 
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Figure 6 
 
Fig. 6. Tryptophan substitutions in the M3 and M4 domains of the GluN1 and 
GluN2B subunits alter glutamate potency. Bar graphs plot glutamate EC50 values 
for peak (Ip; A-B) and steady-state (Iss; C-D) current in lifted cells expressing GluN1 
and GluN2B subunits with various substitutions in the M3 and M4 domains. Asterisks 
indicate EC50 values that differ significantly from that of the wild-type GluN1/GluN2B 
subunit (*P < 0.05, **P < 0.01; ANOVA and Dunnett’s test). Results are the means ± 
S.E of 5-8 cells. The black bars show the EC50 values for the wildtype receptor. 
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Figure 7 
 
Fig. 7. Positions in the M3 and M4 domains of the GluN1 and GluN2B subunits 
interactively regulate glutamate peak current EC50. A,C,E. Graphs plot glutamate 
peak current EC50 values vs. the substituent at position 638, 639 and 818 of GluN1 for 
mutants at GluN2B positions 824, 825 and 637, as indicated. Asterisks indicate 
significant interactions detected using logtransformed peak current EC50 values (*P < 
0.05, ***P < 0.001, ****P < 0.0001; two-way ANOVA). B,D,F. Mutant cycle analysis 
of glutamate peak current EC50 values for GluN1/GluN2B mutant combinations. 
Apparent free energy values associated with various mutations (ΔGx) are given in kcal 
mol-1. Asterisks indicate a statistically significant difference of the apparent 
interaction energy ΔΔGINT from zero energy determined using a one sample t test (*P 
< 0.05; ***P < 0.001; ****P < 0.0001). 
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Figure 8 
 
Fig. 8. Positions in the M3 and M4 domains of GluN1 and GluN2B subunits 
interactively regulate glutamate steady-state current EC50. A,C,E. Graphs plot 
glutamate steady-state current EC50 values vs. the substituent at position 638, 639 
and 818 of GluN1 for mutants at GluN2B positions 824, 825 and 637, as indicated. 
Asterisks indicate significant interactions detected using log-transformed steady-state 
current EC50 values (*P < 0.05; two-way ANOVA). B,D,F. Mutant cycle analysis of 
glutamate steady-state current EC50 values for GluN1/GluN2B mutant combinations. 
Apparent free energy values associated with various mutations (ΔGx) are given in kcal 
mol-1. Asterisks indicate a statistically significant difference of the apparent 
interaction energy ΔΔGINT from zero energy determined using a one sample t test (*P 
< 0.05). 
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Figure 9 
 
Fig. 9. Positions GluN1(Gly638) and GluN2B(Met824) interact to regulate 
NMDA receptor macroscopic desensitization. A. Bar graph shows maximal steady-
state to peak current ratios (Iss : Ip) for current activated by 300 μM glutamate and 
50 μM glycine recorded from cells expressing wild-type GluN1/GluN2B, 
GluN1(Gly638Trp)/GluN2B, GluN1/GluN2B(Met824Trp), and 
GluN1(Gly638Trp)/GluN2B(Met824Trp) subunits. Statistically significant differences in 
maximal apparent desensitization from the value for the wild-type receptor are 
indicated by asterisks (**P < 0.01; ANOVA and Dunnett’s test). B. Graph plots the 
maximal steady-state to peak current ratio vs. the substituent at GluN1(Gly638) for 
GluN2B(Met824), as indicated. Asterisks indicate significant interactions detected 
using values for maximal steady-state to peak current ratio (****P < 0.0001; two-
way ANOVA). C. Mutant cycle analysis of maximal steadystate to peak current ratios 
for the positions GluN1(Gly638) and GluN2B(Met824). Apparent free energy values 
associated with various mutations (ΔGx) are given in kcal mol-1. Asterisks indicate a 
statistically significant difference of the apparent interaction energy ΔΔGINT from zero 
energy determined using a one sample t test (****P < 0.0001). 
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Figure 10 
 
Fig. 10. Positions in the GluN1 and GluN2B subunit M3 and M4 domain 
intersubunit interfaces that interact to regulate ethanol action. A,C, Helical 
wheel plots of the regions of the GluN1 M3 / GluN2B M4 (type 1) and GluN2B M3 / 
GluN1 M4 (type 2) interfaces constituting putative sites of ethanol action. Circles 
represent amino acid positions oriented as in Karakas and Furukawa (2014). One-
letter amino acid codes are used. Significant interactions between positions with 
respect to ethanol sensitivity are indicated by dashed lines; the line thickness 
represents the apparent relative strength of the interaction as indicated by the level of 
significance determined by two-way ANOVA and mutant cycle analysis (thin lines, P < 
0.01 – 0.05; thick lines, P < 0.0001 - 0.001). B, Molecular model of the ethanol site 
formed by the GluN1 subunit M3 domain (gray) and GluN2B subunit M4 domain 
(blue). D, Molecular model of the ethanol site formed by the GluN2B subunit M3 
domain (blue) and GluN1 subunit M4 domain (gray). 
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